Table 1 Demographic and clinical details of samples
Factor | PDAC (n = 32) | HC (n = 32) | AIP (n = 32) |
|---|---|---|---|
Age | 59.31 ± 9.53 | 58.63 ± 10.28 | 58.83 ± 9.76 |
Gender (F/n) | 21.87% (7) | 18.75% (6) | 18.75% (6) |
BMI | 23.21 ± 3.24 | 23.18 ± 3.07 | 24.37 ± 3.09 |
Hypertension (n) | 34.38% (11) | 25% (8) | 6.25% (2) |
Diabetes (n) | 31.25% (10) | 16% (5) | 28.13% (9) |
Jaundice (n) | 25.00% (8) | 0 (0) | 0 (0) |
Tumor location (n) | |||
 Pancreatic head | 40.63% (13) | – | – |
 Pancreatic neck | 12.50% (4) | – | – |
 Pancreatic body | 3.13% (1) | – | – |
 Pancreatic tail | 6.25% (2) | – | – |
 Pancreatic head and body | 12.50% (4) | – | – |
 Pancreatic body and tail | 25.00% (8) | – | – |
TNS staging (n) | |||
 I | 37.50% (12) | – | – |
 II | 28.13% (9) | – | – |
 III | 18.75% (6) | – | – |
 IV | 15.63% (5) | – | – |
CA-19–9 u/ml | 137.10(15.54–379.60) | – | – |